JAMA internal medicine

US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.

JAMA internal medicine

Hidano D, Dhruva SS, Redberg RF

Reporting Device-Associated Death Events to the FDA-Reply.

JAMA internal medicine

Lalani C, Kinard M, Redberg RF

FDA Regulation of Medical Devices-Moving Beyond the Horse and Buggy.

JAMA internal medicine

Holtzman J, Lalani C, Redberg RF

The Next Frontier of Less Is More-From Description to Implementation.

JAMA internal medicine

Latifi N, Redberg RF, Grady D

Conflicts of Interest and Authors of Commentaries in Medical Journals.

JAMA internal medicine

Steinbrook R, Grady D, Redberg RF

Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.

JAMA internal medicine

Lalani C, Kunwar EM, Kinard M, Dhruva SS, Redberg RF

Cycling for Health.

JAMA internal medicine

Redberg RF, Vittinghoff E, Katz MH

Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?

JAMA internal medicine

Crosson FJ, Covinsky K, Redberg RF

Persistent Gender Pay Gaps in Medicine: What Is Good for the Goose Is Better for the Gander's Paycheck.

JAMA internal medicine

Redberg RF, Parks AL, Rubin JB

Gender, Race, Ethnicity, and Sexual Orientation of Editors at Leading Medical and Scientific Journals: A Cross-sectional Survey.

JAMA internal medicine

Salazar JW, Claytor JD, Habib AR, Guduguntla V, Redberg RF

Pages